Posted Feb. 13, 2020. Past health advisories and alerts are archived for historical purposes and are not maintained or updated.
As of February 4, 2020, a total of 2,758 hospitalized e-cigarette or vaping-associated lung injury (EVALI) cases or deaths have been reported from all 50 states, the District of Columbia, and two U.S. territories, including 64 deaths. The Washington State Health Officer has requested provisional reporting of EVALI cases for an additional 120 days.
Vitamin E acetate is strongly linked to the EVALI outbreak; however, evidence is not sufficient to rule out the contribution of other chemicals of concern. Emergency department visits related to e-cigarette, or vaping, products continue to decline after peaking in September 2019. According to the Centers for Disease Control & Prevention, reasons for the decline may be related to the following:
While the multi-state outbreak of vaping-associated lung injury has waned nationally, the Centers for Disease Control and Prevention (CDC) and public health agencies in Washington State continue to investigate vaping-associated lung injury to better understand its prevalence and cause(s). The latest information about the outbreak can be found on the CDC and Department of Health websites.
National data from patient reports and product sample testing show tetrahydrocannabinol (THC)-containing vapor products, particularly from informal sources like friends, family, or in-person or online dealers, are linked to most EVALI cases and play a major role in the outbreak. Vitamin E acetate, a product used to produce THC-containing vapor products, is also strongly linked to the EVALI outbreak. Vitamin E acetate has been found in product samples tested by FDA and state laboratories and inpatient lung fluid samples tested by CDC from geographically diverse states. Evidence is not sufficient to rule out the contribution of other chemicals of concern, including chemicals in either THC or non-THC products, in some of the reported EVALI cases.
For additional clinical considerations and additional resources for healthcare providers, please see: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease/healthcare-providers/index.html
For patients who want to quit vaping nicotine the best practices are described here: https://www.drugabuse.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-treatments-tobacco-dependence and local resources are listed here: https://srhd.org/media/documents/CessationSheet.pdf